Emergent BioSolutions Downgraded as Narcan Sales Wane and Debt Remains a Concern
On September 6, 2026, Emergent BioSolutions Inc. (NYSE: EBS) slipped from a Buy to a Hold rating when Seeking Alpha anal...
Read story →Tag: Otc
View all →
OTC Markets Group Beats Q2 2026 Earnings Expectations on Strong Trading Volumes and Corporate Services Growth
OTC Markets Group Inc. (OTCM) surprised Wall Street on August 5, 2026 by posting second‑quarter results that outpaced ...
Read story →
dynaCERT Inc. Announces Up to $5 Million Convertible Private Placement to Fund HydraGEN Sales
dynaCERT Inc. (TSX: DYA, OTCQB: DYFSF, FRA: DMJ) announced on June 18 2026 that it will offer convertible unsecured unit...
Read story →